Novo NordiskNuòhé Nuòdé诺和诺德and / withyǔ与OpenAI (AI company)OpenAIOpenAIto reach / to concludedáchéng达成strategiczhànlüè战略partnership / cooperationhézuò合作,in order toyǐ以artificial intelligencerén gōng zhìnéng人工智能to acceleratejiāsù加速drug / medicineyàowù药物research and developmentyán fā研发。
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
and / with
yǔ
与
OpenAI (AI company)
OpenAI
OpenAI
to reach / to conclude
dáchéng
达成
strategic
zhànlüè
战略
partnership / cooperation
hézuò
合作
in order to
yǐ
以
artificial intelligence
rén gōng zhìnéng
人工智能
to accelerate
jiāsù
加速
drug / medicine
yàowù
药物
research and development
yán fā
研发
Denmark
Dānmài
丹麦
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Novo Nordisk
Nuòhé Nuòdé
诺和诺德
with
yǔ
与
OpenAI
OpenAI
OpenAI
on (date marker)
yú
于
April 14th
4 yuè 14 rì
4月14日
to announce
xuānbù
宣布
to reach
dáchéng
达成
strategic
zhànlüè
战略
partnership
hézuò
合作
to cover / to encompass
hángài
涵盖
drug / medicine
yàowù
药物
research and development
yán fā
研发
manufacturing / production
shēngchǎn
生产
and / as well as
jí
及
commercial / business
shāngyè
商业
operations
yùnyíng
运营
entire chain / end-to-end
quán liàntiáo
全链条
the said
gāi
该
partnership
hézuò
合作
aimed at / with the goal of
zhǐzài
旨在
by means of / with the help of
jièzhù
借助
artificial intelligence
rén gōng zhìnéng
人工智能
to shorten / to reduce
suōduǎn
缩短
drug
yàowù
药物
from
cóng
从
research
yánjiū
研究
to
dào
到
clinical
línchuáng
临床
application / use
yìngyòng
应用
(possessive / modifier particle)
de
的
cycle / timeline
zhōuqī
周期